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Background: Due to the different properties of the contrast agents, the lung perfusion maps as measured by
99mTc-labeled macroaggregated albumin perfusion scintigraphy (PS) are not uncommonly discrepant from those
measured by dynamic contrast-enhanced MRI (DCE-MRI) using indicator-dilution analysis in complex pulmonary
circulation. Since PS offers the pre-capillary perfusion of the first-pass transit, we hypothesized that an inflow-
weighted perfusion model of DCE-MRI could simulate the result by PS.
Methods: 22 patients underwent DCE-MRI at 1.5T and also PS. Relative perfusion contributed by the left lung was
calculated by PS (PSL%), by DCE-MRI using conventional indicator dilution theory for pulmonary blood volume
(PBVL%) and pulmonary blood flow (PBFL%) and using our proposed inflow-weighted pulmonary blood volume
(PBViwL%). For PBV
iw
L%, the optimal upper bound of the inflow-weighted integration range was determined by
correlation coefficient analysis.
Results: The time-to-peak of the normal lung parenchyma was the optimal upper bound in the inflow-weighted
perfusion model. Using PSL% as a reference, PBVL% showed error of 49.24% to −40.37% (intraclass correlation
coefficient RI = 0.55) and PBFL% had error of 34.87% to −27.76% (RI = 0.80). With the inflow-weighted model,
PBViwL% had much less error of 12.28% to −11.20% (RI = 0.98) from PSL%.
Conclusions: The inflow-weighted DCE-MRI provides relative perfusion maps similar to that by PS. The discrepancy
between conventional indicator-dilution and inflow-weighted analysis represents a mixed-flow component in
which pathological flow such as shunting or collaterals might have participated.
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Accurate assessment of pulmonary perfusion is important
to the understanding of the pathophysiology of many
cardiopulmonary diseases. Changes in regional lung
perfusion can be observed in pulmonary diseases such as
pulmonary embolism and chronic obstructive pulmonary* Correspondence: wu.mingting@gmail.com
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reproduction in any medium, provided the ordisease [1] and sequestration [2], and in cardiovascular
diseases such as pulmonary stenosis or tetralogy of Fallot
(TOF) [3]. At present, the conventional method measuring
regional pulmonary perfusion in clinical practice is pul-
monary scintigraphy (PS) [4,5].
In recent years, MR imaging has become a competitive
technique for pulmonary imaging [6-9]. MR imaging has
the advantages of simultaneous acquisition of detailed
anatomical images and multiple functional information to
assist diagnosis without the cost of ionization radiation ex-
posure. First-pass dynamic contrast-enhanced MR imaging
(DCE-MRI) using intravenous bolus injection of contrast. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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normality in a semi-quantitative manner [1,6,10]. The
accuracy of DCE-MRI in measuring regional pulmonary
perfusion map (rPPM) has been validated by experimental
studies on animal models using injected microsphere
measurements as the standard [11,12]. Several studies have
shown that MR imaging provides consistent rPPM
compared with PS on patients with pulmonary embolism,
emphysema [13] or prediction of postoperative lung
function [14,15].
In patients with complex pulmonary circulation (CPC),
there may be presence of pathological flow such as systemic
shunting or collaterals. In these conditions, discrepancy
between the rPPM by PS and DCE-MRI using the conven-
tional dilution analysis is not uncommonly observed in
clinical practice. The contrast agent used in PS, namely
technetium-99m (99mTc)-labeled macroaggregated albumin
(MAA)(99mTc-MAA), is a large aggregate with particle size
on the order of some tens to about a hundred micrometers.
Following intravenous injection, the 99mTc-MAA gets
entrapped in the pre-capillary intravascular space and tem-
porarily obstructs approximately 1% of the total pulmonary
capillary bed [16]. This capillary blockade mechanism of
99mTc-MAA indicates that the PS solely provides inflow
perfusion information in normal pulmonary circulation. On
the contrary, the gadolinium chelate used for DCE-MRI is
of several nanometers in diameter. It could thus pass freely
through the capillaries to the systemic flow and re-
circulation in normal lungs; or abnormally, via shunt/collat-
eral flow to the pathological lungs such as pulmonary
sequestration, which we called “mixed-flow phase” and
could not be removed by gamma-variate fitting to the first-
pass transit in the indicator dilution model of DCE-MRI.
Due to the presence of mixed-flow phase in DCE-MRI, we
hypothesized that an inflow-weighted model of DCE-MRI
could reduce discrepancy between rPPM by PS and DCE-
MRI. In the present study, we developed an inflow-weighted
model of DCE-MRI on 22 patients of CPC receiving both PS
and DCE-MRI. We aimed to compare the inflow-weighted
rPPM measured by PS and DCE-MRI in patients with CPC,
which may improve the clinical utility of DCE-MRI.
Methods
The inflow-weighted DCE-MRI analysis
In conventional indicator dilution theory, the perfusion
parameters can be derived from the series of DCE-MRI
acquired throughout the first-pass contrast agent passage
[17]. In particular, the relative pulmonary blood volume
(rPBV) is given by the integration of the gamma-variate
function-fitted first-pass signal intensity-time (SI-time)




s tð Þdt ð1ÞAssuming that the concentration of the contrast agent
is proportional to the signal enhancement, the relative
mean transit time (rMTT) can be computed as the









And the relative pulmonary blood flow (rPBF) is obtained




In clinical reality, however, the conventional definition of
first-pass transit may encounter difficulty in the case of
CPC. In order to match the “pre-capillary” components of
PS by DCE-MRI, we proposed an “inflow weighted”
modification on the perfusion analysis method for
DCE-MRI as follows. Instead of performing integration
throughout the entire first-pass transit as in Eqs.[1]-[3],
the integration range in the new method is restricted to





s tð Þdt ð4Þ
where tmax, the upper bound of integration, is chosen in
this study as the time where the normal lung parenchyma
shows maximum signal intensity, which is often referred
to as time-to-peak (Figure 1). One can see that if the
integration upper bound is chosen to approach infinity
instead, rPBViw would return to conventionally defined
rPBV as in indicator dilution theory [10]. The rationale
for choosing the time-to-peak as the integration upper
bound was to ensure the wash-in portion of the pul-
monary arterial phase was predominantly included,
which is anticipated to give DCE-MRI results similar to
those from PS. Validation of the choice of tmax is
illustrated in a section below.
Subjects
The study was approved by our institution's Internal
Review Board Committee and informed consent was
obtained from patients or patients' parents. The study
was a second analysis of part of data which was collected
in a previously published study [18]. A total of 22
patients (12 males and 10 females; age range = 3 months
to 77 years, mean = 20.8 years) with CPC due to a variety
of diseases without or with surgical correction were en-
rolled in our study. Patients with history of renal disease
or impaired renal function were not enrolled. The details
Figure 1 Schematic plot of integration range for PBV and
inflow-weighted analysis. Arrowhead indicates the upper bound
of integration for rPBV. The arrow indicates tmax, time-to-peak for the
normal lung parenchyma, which was defined as the upper bound of
integration for inflow-weighted analysis.
Table 1 Diagnostic information for patients included in
this study
Patient Age Sex Diagnosis Surgery PSL% (%)
1 9 y M TOF 97.3
2 6 y M TOF Repair 0.0
3 3 y F TOF 33.9
4 2 y F Complex CHD, FSV Hemi-Fontan 65.2
4 2 y F Complex CHD, FSV Hemi-Fontan 21.2
5 4 y M Complex CHD, FSV Hemi-Fontan 60.3
5 4 y M Complex CHD, FSV Hemi-Fontan 1.5
6 8 y M Complex CHD, FSV Fontan 82.5
6 8 y M Complex CHD, FSV Fontan 13.6
7 8 y F Complex CHD, FSV Fontan 68.2
7 8 y F Complex CHD, FSV Fontan 1.1
8 32 y F Sequestration spectrum 43.7
9 3 m F Sequestration spectrum 29.2
10 44 y F Sequestration spectrum 38.4
11 61 y F Swyer-James 7.9
12 74 y M Swyer-James 68.4
13 18 m M TAPVR Repair 7.3
14 17 y M PAPVR 98.5
15 60 y M Lung cancer 28.9
16 27 y M Pulmonary hypertension Rt lung
transplantation
30
17 77 y M PDA 42.2
18 12 y M VSD PPS Repair 56.1
19 2 y F VSD Repair 52.8
20 3 m M Hypogenetic 72.5
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left lung measured by PS are shown in Table 1.
These patients underwent both DCE-MRI and PS to
evaluate the CPC. Four patients with Fontan or bilateral
Glenn’s surgery received two injections in both upper
and lower limbs on two different days for perfusion
scintigraphy, and with an interval of 20 minutes for
DCE-MRI. The perfusion data from different limbs were
analyzed and compared respectively, hence making the
total number of cases 26.lung syndrome
21 71 y F Pulmonary
thromboembolism
32.7
22 5 m F Sequestration
spectrum + PPS
81.6
Note – TOF: tetralogy of Fallot, CHD: congenital heart disease, FSV: functional
single ventricle, TAPVR: total anomalous pulmonary venous return, PAPVR:
partial anomalous pulmonary venous return, PDA: patent ductus arteriosus,
VSD: ventricular septal defect, PPS: peripheral pulmonary stenosis.
PSL% (%), percentage of left lung perfusion by Tc99m-MAA
perfusion scintigraphy.Data acquisitions
Lung perfusion scintigraphy
Pulmonary perfusion scintigraphy was performed after
intravenous injection of 99mTc-MAA. Six static views
with anterior, posterior and right-left lateral oblique
posterior and anterior projections were obtained with a
dual-head gamma camera (Siemens E-Cam, Erlangen,
Germany). In both anterior and posterior images, manu-
ally selected regions of interest (ROIs) were drawn over
the left and right lungs. The percentage of perfusion of
the lungs was calculated by dividing the mean radio-
activity of the left lung measured from anterior and pos-
terior views, and divided by the mean radioactivity of
the whole lungs (PSL%).
PSL% = left lung / (left lung + right lung) × 100% [5]
To obtain regional perfusion ratios, both lungs were
divided to six ROIs of the upper right, middle right,
lower right, upper left, middle left, and lower left lungs.
The percentage perfusion ratio for each regional ROI
was calculated separately (PS%).Cardiac catheterization angiography
In 16 patients, cardiac catheterization angiography
(Advantx LC/LP; GE Healthcare) was performed according
to clinical indications within 3 months of the MRI study.
Catheterization for the left heart and the right heart were
both performed. The left ventriculography and aortography
were performed first, followed by right ventriculography
and pulmonary arteriography. Pressure measurements
were performed at right ventricle and pulmonary trunk.
Selective injections of aortic arch branches and major
aortopulmonary collateral arteries were performed as
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in cases with suspected peripheral pulmonary stenosis.
In cases with pulmonary atresia, wedged pulmonary
venogram was performed to retrograde visualization of
the pulmonary artery branches as needed.
MR Imaging
Anatomical MR imaging
All MR images were acquired on a 1.5 Tesla system
(GE Healthcare, Signa Cvi, Milwaukee, WI). For patients
who can perform breath-holding, anatomic images were
acquired with ECG-gated double inversion-recovery-
prepared black-blood fast spin-echo sequence (TI/TR/
TE/ETL = 340ms/1 R-R/4.7ms/32). For patients who
could not hold their breath well, spin-echo T1-weighted
images (TR/TE = 1 ~ 2 R-R interval/25ms) were obtained
with ECG-gated and respiratory compensation during
quiet breathing.
Dynamic contrast-enhanced MR imaging
DCE-MRI measurements were acquired by using an
inversion-recovery-prepared segmented EPI technique
[19] with cardiac gating. Imaging parameters, adjusted
dependent on individual heart rates, were usually TI/TR/
TE = 180/6.5/1.2 msec, ETL = 4, matrix size = 128×128,
and interpolated to 256×256 for display. Scan slice was 6–
8 mm in coronal plane. Patients were asked to hold their
breath during scans as long as possible. Patients younger
than 8 years were sedated and consequently were imaged
during quiet breathing. For these patients, the SI-time
curves showed respiration-related fluctuations which could
nevertheless be smoothed via gamma-variate fitting as
stated in the next section. Cardiac gating was used to avoid
image misregistration, particularly for lung parenchyma
near the border of mediastinum and the heart where the
blood flow was relatively large and could have strong
impact on pulmonary perfusion parameters. The number
of slices acquired was dependent on the heart rate and
about seven slices in two R-R intervals [19]. A bolus of
0.05 mmol/Kg Gd-DTPA (Magnevist, Schering, Germany)
was injected intravenously after the image acquisition
started, using either an MR-compatible power injector at a
speed of 3 ml/sec for age > 15 years and manual injection
as fast as possible for age < 15 years. A total of 40 ~ 60
frames, separated by two R-R intervals from one another,
were obtained at each coronal slice locations.
Contrast-enhanced 3D MR angiography
The MR angiogram was acquired in coronal orientation
using elliptical k-space gradient-echo imaging with TR/
TE = 4.8ms/1.5ms, flip angle = 15°, matrix = 256 × 160,
and field of view = 150 ~ 320 mm after the injection of
Gd-DTPA (0.1 mmol/kg). Multiplanar reconstruction
with maximal intensity projection was done for theinterrogated vessels to evaluate the vascular morphology
together with anatomical spin-echo images.Imaging analysis
Anatomical evaluation
One observer (KSH) who read the cardiac catheter
angiography was blinded to the MR imaging findings and
perfusion scintigraphy results with emphasis on evaluating
the pulmonary arteries, aortopulmonary collaterals, and
aortopulmonary shunts [20].
The anatomical axial and contrast-enhanced 3D MR
angiographic imaging was evaluated with the report and
imaging of catheterization angiography by two observers
(YLH, MTW) in consensus. They were blinded to the
results of DCE-MRI and PS.
The anatomical evaluation results were used for clinical
diagnosis and to explain the possible disagreement between
DCE-MRI and PS findings.DCE-MRI Data analysis
An institutionally developed program on MATLAB pro-
gramming environment (MathWorks, Natick, MA) was
used to define the lung as ROI after excluding the heart and
great hilar vessels as described previously [21]. Briefly, ROIs
of both lungs were manually selected for each slice and a
threshold-masking method was used to exlcude pixels with
signal intensities higher than threshold. The threshold was
adjusted so that the mask fit well with the anatomical
borders of the lung fields. Following ROI selections, we
performed baseline-intensity-subtracted and gamma-variate
fittings of the SI-time curve to obtain the first-pass transit.
The conventional perfusion parameters were thus derived
according to Eqs.[1] to [3]. The perfusion ratios of the left
lung (Eq [5]) could then be derived (PBVL% and PBFL%).
The ROIs of left and right lungs were further divided into 3
zonal ROIs, as upper, middle and lower zones, again
analogous to that used in PS, in order to compare
DCE-MRI with PS per person and per zone. For
inflow-weighted method, rPBViw was obtained using
Eq.[4] for both left lung perfusion ratio and 6-zone
ROI analysis. The ROIs were identical to those in the
indicator dilution method.Relative pulmonary perfusion maps (rPPM)
To compare with PS, relative pulmonary perfusion maps
(rPPM) of rPBV and rPBViw were calculated from DCE-
MRI data. ROIs of pulmonary parenchyma were selected
for each slice [21]. Analysis was then executed for every
ROI in a pixel-by-pixel basis. Spatial smoothing was
applied to decrease the influence of noise. rPPM was
calculated from each slice and summed up as projective
rPPM of whole lungs for each patient.
Figure 2 Influence of integration range ti on rPBViw. Correlation
coefficient between PBViwL%(ti) and PSL% reached maximum value of 0.981
at ti −0.3sec, which is almost the time-to-peak (ti =0). We used time-to-
peak tmax as the upper bound for inflow-weighted analysis of DCE-MRI.
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To determine the optimal integration range in Eq.[4] for
rPBViw so it would be close to rPPM by PS, we developed
a method to search for the optimal upper boundary of the
integration range in Eq.[4], as detailed below.
We first varied the integration range in Eq.[4] by
introducing a variable ti into the integral:
rPBV iw tið Þ ¼
Z tmaxþti
0
s tð Þdt ð5Þ
where ti is the time interval from tmax. In this study,
using no more than 60 frames for each slice of DCE-
MRI, ti ranged from −5 to 30 secs. Equivalently
speaking, rPBViw is now a function of ti, or rPBViw(ti).
The optimal ti is the one where rPBViw(ti) is most similar
to rPPM by PS. To find this optimal ti, the DCE-MRI data
were first analyzed to yield rPBViw(ti), from which the
corresponding PBVtwL%(ti) values were derived. These PBV
tw
L%
(ti) values were compared with the nuclear medicine data
PSL%. In order to assess the overall agreement for the 26
cases, we calculated the correlation coefficient between
PBVtwL%(ti) and PSL% for each ti. Consequently, the optimal
ti value for PBVtwL%(ti) was chosen as the one that yielded
the largest correlation coefficient, and was used for all
regional inflow-weighted analysis as stated in previous
sections.
Statistical analysis
The overall agreement between PS and DCE-MRI was
assessed using the intraclass correlation coefficient [22],
which produces measures of consistency or agreement of
values within cases. In addition, graphical visualization of
the agreement between perfusion ratios of PS and DCE-
MRI was assessed using the Bland-Altman analysis [23].
Results
Figure 2 shows the effects of integration range used in
inflow-weighted DCE-MRI. The choice of the integra-
tion upper bound greatly influenced the calculated
perfusion ratio. It is seen that the integration range
corresponding to the largest correlation coefficient of
0.98 is very close to the time-to-peak (ti = −0.3 sec). For
computational convenience, the time-to-peak tmax was
therefore chosen as the optimal integration upper bound
for PBVtwL%(ti).
Table 2 lists the perfusion parameters including rPBV,
rPBF, and rPBViw in both left and right lungs, and the
corresponding percentage of perfusion of the lungs. The
Bland-Altman plots [23] in Figure 3A and B show the
overall agreement between PSL% and PBVL% or PBFL%
respectively. For rPBV versus PS (Figure 3A), the mean
difference was 4.43%, with upper and lower limits of two
standard deviations at 49.24% and −40.37% respectively.The intraclass correlation coefficient [22] between these
two methods was RI = 0.55 (95% confidence interval
[0.22, 0.77]). For rPBF versus PS (Figure 3B), the mean
difference was 3.55% (upper and lower limits at 34.87%
and −27.76% respectively), with intraclass correlation coeffi-
cient RI = 0.80 and 95% confidence interval [0.60, 0.90].
These results suggest that both rPBV and rPBF showed
substantial discrepancy with PS in our subjects with CPC.
With the inflow-weighted model, PBVtwL% (Figure 3C),
the range of PBViwL% − PSL% discrepancy was 12.28%
and −11.20% respectively. Mean difference was 0.54% and
RI = 0.98 (95% confidence interval [0.96, 0.99]).
The 6-zonal correlative study to PS% also showed similar
improvement in inflow-weighted analysis. Zonal PBV% and
PBF% are plotted versus PS% in Figure 4A and B respect-
ively. Figure 4C shows PBVtw% with integration upper
boundary chosen at the point of time-to-peak.
Example cases in Figure 5 show a 3-month-old girl with
lung sequestration spectrum. Figure 6 shows a 9-year-old
boy with repaired TOF with bilateral peripheral pulmonary
stenosis. The rPBViw maps (Figures 5I, 6I) had better
agreement with the PS perfusion map in Figures 5G and
6G respectively.
Discussion
This is the first study to systematically investigate the
discrepancy between rPPM by DCE-MRI and PS. We
showed that the rPPM by inflow-weighted DCE-MRI was
very close to PS, as compared to the indicator dilution
DCE-MRI. The discrepancy between the indicator dilution
DCE-MRI and PS (and analogically, between indicator
dilution vs. inflow-weighted DCE-MRI) was mixed-flow
components (which mixed with normal re-circulation and
abnormal shunting or collateral flow) after the first pass
Table 2 Perfusion parameters including rPBV, rPBF, and rPBViw in both left and right lungs





(%)Left Right Left Right Left Right
1 1587157 136884 92.1 6011058 4782211 55.7 609401 266672 69.6
2 4184 789734 0.5 1809734 2426058 42.7 174724 346700 33.5
3 1719347 3091112 35.7 6218989 9614279 39.3 776058 1315645 37.1
4 753700 438674 63.2 2488098 5723882 30.3 248556 289924 46.2
4 216036 881601 19.7 4039850 3424204 54.1 312637 395298 44.2
5 1995797 1441262 58.1 7676676 11091451 40.9 398871 415493 49.0
5 917936 3760608 19.6 7653578 11810187 39.3 492393 688432 41.7
6 1536567 438084 77.8 4343320 1043287 80.6 569178 166541 77.4
6 588633 2753401 17.6 1892854 7243710 20.7 137425 582693 19.1
7 1174442 527101 69.0 3635513 1593516 69.5 466754 168287 73.5
7 7572 475954 1.6 575611 1198385 32.4 67059 339961 16.5
8 951568 1138064 45.5 3028626 3167695 48.9 301882 343895 46.7
9 247186 525474 32.0 2329719 1522402 60.5 303914 345572 46.8
10 431442 671381 39.1 2247450 1892474 54.3 192487 265560 42.0
11 233023 876317 21.0 1139290 3049546 27.2 68795 179289 27.7
12 822685 484056 63.0 2352025 2152277 52.2 199549 153775 56.5
13 178215 1726389 9.4 2506232 5197082 32.5 461815 1515113 23.4
14 1047594 49729 95.5 2775160 2076806 57.2 434155 95379 82.0
15 589305 1288370 31.4 2272678 3708367 38.0 188174 348941 35.0
16 609832 1500893 28.9 3780830 3990400 48.7 253484 394298 39.1
17 357424 524454 40.5 1111662 1479468 42.9 99362 121789 44.9
18 736335 739105 49.9 2415417 2495677 49.2 339765 353479 49.0
19 1297335 2001479 39.3 3852779 6041393 38.9 665898 1033059 39.2
20 2784430 1080745 72.0 8378116 3174017 72.5 1080888 410446 72.5
21 363549 612778 37.2 1507310 2132760 41.4 165563 253541 39.5
22 774967 162284 82.7 2305914 1037507 69.0 473009 202386 70.0
A.U. = arbitrary unit.
Figure 3 Bland-Altman analysis plots of the percent flow to the left lung compared with PS, (A) rPBV (B) rPBF (C) rPBViw analysis.
rPBViw shows the best consistency with the PS. PS, perfusion scintigraphy, rPBV, relative pulmonary blood volume, rPBF, relative pulmonary blood
flow, rPBViw, inflow-weighted relative pulmonary blood volume.
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Figure 4 Bland-Altman analysis plots of the percent flow to 6 ROIs compared with PS, (A) rPBV (B) rPBF (C) rPBViw analysis. rPBViw
shows the best consistency with PS.
Figure 5 A case of a 3-month-old female with pulmonary sequestration spectrum. (A, B) Axial ECG-gated spin-echo T1WI at diaphragm
level (A): an anomalous arterial supply from descending aorta (arrow). (B), the artery courses serpiginously (arrowhead) supplying the basal
segments of the left lower lung. (C) Contrast-enhanced 3D MR angiography: An anomalous arterial supply from aorta (arrow) to the left lower
lung (arrowhead). The course and branching pattern in the basal segments was identical to those confirmed by catheter angiography (D). (E)
DCE-MRI after bolus injection. Two ROIs were chosen on left upper lung and left lower lung. (F) SI-time curve of left low lung showed a delayed
bolus-arrival as compared to curve of left upper lung. (G) Tc-99M-MAA pulmonary perfusion scintigraphy (posterior-anterior view) shows
decreased perfusion over the left lower zone. (H) rPBV map of whole lungs calculated from DCE-MRI. There was no obvious flow deficit in rPBV
map. (I) rPBViw map of the whole lungs. It is similar to Figure (H) except that inflow-weighted analysis was calculated instead of rPBV analysis.
rPBViw map showed a flow deficit in the left lower lung.
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Figure 6 (A-C) A serial of ECG-gated spin echo T1-weighted image. At the carinal level (A), a moderate degree of stenosis (arrow) of left
pulmonary artery was noted. At right pulmonary artery level (B), the dilated right pulmonary artery shows rapid tapering (asterisk). Note the left
pulmonary artery shows post-stenotic dilatation (arrow). At the lower lung level (C), the right pulmonary artery is tiny (curved arrow), in contrast
to the left lower pulmonary artery (arrowhead). Ao: aorta; PT: pulmonary trunk. (D) Catheter angiography with contrast medium injection from
right ventricle shows dilated PT, left pulmonary artery (arrowhead) and right pulmonary artery with an abrupt tapering (asterisk). Note there is a
tiny branch with decrease flow (curved arrow) in the right lower lung. (E). DCE-MRI after bolus injection. ROIs were chosen to cover the whole
left lung (red) and right lung (green). Pixels with high intensity were considered as vessels and excluded from ROIs. (F) SI-time curves obtained
from DCE-MRI for the left and right lungs. (G) Tc99M-MAA pulmonary perfusion scintigraphy (posterior-anterior view) shows almost no detectable
perfusion in the right lung. (Right, 97.3%, Left, 2.7%). (H) rPBV map of whole lungs showed a small but observable flow in the right lung. (I)
rPBViw map of the whole lungs was similar to PS and showed no detectable flow in the right lung.
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inflow-weighted component of DCE-MRI, which might
improve DCE-MRI for comprehensive evaluation of CPC.
There are great differences in particle sizes of DTPA
and MAA. Normally, MAA particles (around 10–100
micrometer in size) are much larger than red blood cells
(7 micrometer) and cannot pass through the capillaries
normally, while DTPA particles are much smaller (<10
nanometer in size) and continually flow to the left heart
system, travel back to the right heart system and re-
circulate to the pulmonary artery as secondary pass. In
terms of hemodynamic pathway, PS purely represents
the inflow component of the first pass transit of pul-
monary perfusion, while DCE-MRI contains inflow-
weighted and mixed-flow phases contaminated by
normal re-circulation or abnormal shunting or collateral
flow.In previous investigations comparing rPPM by dilution-
model DCE-MRI (rPBF) vs. PS in human subjects, the
inter-modality correlation has been reported as generally
good (r = 0.84 ~ 0.92) [1,13-15,24]. Taking an in-depth
look, large discrepancies between rPPM by PS and dilution
model DCE-MRI have been observed, but neglected, in
certain cases of these studies. For example, one-third of the
patients with malignant stenosis of the pulmonary artery
showed about 40% discrepancy in rPPM between PS and
DCE-MRI [25]; also reported in patients with a variety
of lung diseases [26]. All the evidence [25,26] together
with the present study indicates that rPPM by PS and
by dilution method DCE-MRI is not equivalent in all
pulmonary diseases.
In DCE-MRI, “wash-out” effect actually starts during
the up-slope part in a much less magnitude than the
“wash-in” effect; therefore, we used the term “inflow-
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in Figure 2, the optimal cut-off point to represent the
inflow-weighted part was the curve peak of the control
lung parenchyma. According to our previous study on
bolus tracking in CPC [18], at this particular time point,
the front end of the contrast bolus had almost arrived at
the left heart. Therefore, the systemic collateral flow due
to aberrant artery (as Figure 5) or stenotic pulmonary artery
(as Figure 6) would largely be excluded in the inflow-
weighted analysis. We think this is the hemodynamic
foundation of rPBViw that could identify inflow-weighted
component of CPC.
It is reasonable to speculate that subtraction of rPBV by
rPBViw is equivalent to the mixed-flow phase of rPBV. The
mixed-flow phase of rPBV might be a meaningful indicator
in CPC. With integrated usage of the temporal correlation
technique for bolus tracking visualization [18], differential
assessment of inflow-weighted phase vs. mixed-flow phases
of rPPM is potentially of great impact on the pathophysio-
logical evaluation of CPC.
One may propose a variation of inflow-weighted DCE-
MRI; e.g. integration of area-under-curve to the peak of
normal lung and the peak of abnormal lung separately.
In fact, we have tested it and found the results were
similar to that by the conventional indicator-dilution
model (rPBV and rPBF).
The rPBV and rPBViw by DCE-MR are relative, not
absolute measurements. We found a very high inter- and
intra-rater variability in the measurement of arterial input
function; therefore, we did not apply AIF correction to
obtain absolute PBV. In addition, we cannot calculate
rPBFiw since we cannot estimate the mean transit time
for inflow.
There was perfusion defection around the hilar region
in rPPM of rPBV or rPBViw, as compared to PS
(Figures 5G-I, 6G-I). This was owing to the partial volume
effect of the large hilar vessels which were over-sized
masked by signal intensity-threshold method during ROI
selection of lung parenchyma. Although most studies use
one or two slices only for rPBV or rPBF [10,11], we believe
application of faster scan technique to improve the scan
coverage and slice thickness would solve this phenomenon.
This study design had limitations as the subjects
comprised a wide variety of disease entities and a wide
range of ages, in retrospective analysis. A prospective
study on a specific disease entity such as Fontan physi-
ology incorporated with more hemodynamic information
in additional to PS would further validate the clinical
impact of our proposed method.
Conclusions
In conclusion, the present study supported our hypothesis
that discrepancies of rPPM between PS and the indicator-
dilution model of DCE-MRI in CPC could be improved bythe implantation of the inflow-weighted model of DCE-
MRI. DCE-MR can identify inflow-weighted and mixed-
flow phases in the full spectrum of pulmonary perfusion;
therefore, it could be a substitute for PS in clinical practice.
We suggest that, in patients with complex cardiopulmonary
disease, the conventional indicator-dilution model and our
inflow-weighted model of DCE-MRI should both be
integrated for comprehensive evaluation of CPC.
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